OKLAHOMA CITY, April 09, 2018 -- Federman & Sherwood announces that on April 6, 2018, a class action lawsuit was filed in the United States District Court for the Central District of California against Colony NorthStar, Inc. (NYSE:CLNS). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is February 28, 2017 through March 1, 2018.
Plaintiff seeks to recover damages on behalf of all Colony NorthStar, Inc. shareholders who purchased common stock during the Class Period and are therefore a member of the Class as described above. You may move the Court no later than Tuesday, June 5, 2018 to serve as a lead plaintiff for the entire Class. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.
If you wish to discuss this action, obtain further information and participate in this or any other securities litigation, or should you have any questions or concerns regarding this notice or preservation of your rights, please contact:
Robin Hester
FEDERMAN & SHERWOOD
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
Email to: [email protected]
Or, visit the firm’s website at www.federmanlaw.com


Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Amazon Explores AI Content Marketplace With Media Publishers
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss 



